Open in app

Hat trick Approval for India Against Covid-19

img-1
Total Views:
103
img-1
Total Likes:
13
img-1
Published By:
Peeyush Ghalot
img-1
Published On:
29-12-2021

The Central Drugs Standard Control Organization (CDSCO) has proposed that three new weapons be granted emergency use authorization.

COVOVAX is the Indian version of Novavax Inc.'s Covid19 vaccine, which is made under licence from the Serum Institute of India (SII). It's a protein-based nanoparticle vaccination. It is given intramuscularly, with two dosage schedules of day 0 and day 21.

(Picture: - MyGov)

CORBEVAX is a brand of corbevax. Biological-E, situated in Hyderabad, has created India's first indigenously generated RBD protein sub-unit vaccine against Covid-19. It's a three-peat! After Covaxin and Zycov-D, it's the third vaccine created in India. It is given intramuscularly in two doses, one on day 0 and the other on day 28.  

MOLNUPIRAVIR is an antiviral medication. Adult COVID-19 patients who are at high risk of illness development are treated with this drug. Molnupiravir is an antiviral that works via mutagenesis to stop SARS-CoV-2 from replicating.